Literature DB >> 3817036

Purification and properties of rat lens methionine adenosyltransferase.

A M Geller, M Y Kotb, H M Jernigan, N M Kredich.   

Abstract

Methionine adenosyltransferase (MAT) has been partially purified from rat lenses using a combination of ammonium sulfate fractionation and hydrophobic chromatography on phenyl Sepharose columns. The partially purified enzyme resembles purified Type II MAT from non-hepatic tissues. The Km for methionine is 3.0 microM, and the Km for ATP is 80 microM. The enzyme is activated by potassium ions (25-50 mM), and inhibited by higher concentrations of potassium. A divalent cation (magnesium or manganese) is essential for activity. The Vmax with magnesium is about five times higher than with manganese, but the optimal manganese concentration is around 2.0 mM, compared with 10-20 mM for magnesium. The enzyme is active over a broad pH range, with optimal activity between pH 7.0 and 8.0. The enzyme is inhibited by all three of its products, phosphate, pyrophosphate, and S-adenosylmethionine. Individually phosphate and pyrophosphate are weak inhibitors, but in combination they show a marked synergistic inhibitory effect. Tripolyphosphate is also an effective inhibitor. The inhibition of the enzyme by the cataractogenic agent, dimethylsulfoxide, further confirmed the similarity to Type II MAT.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3817036     DOI: 10.1016/0014-4835(86)90077-1

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

1.  Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine.

Authors:  T L Byers; T L Bush; P P McCann; A J Bitonti
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Methylation and carbamylation of human gamma-crystallins.

Authors:  Veniamin N Lapko; David L Smith; Jean B Smith
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.